Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST002764)
(Analysis AN004498)
Metabolite
Structure
F1
F2
FA 22:2; (docosadienoic acid)
ME716286
1.21
0.79
FA 8:0; (caprylic acid)
ME716292
0.79
1.21
PE 36:4;
ME716372
1.05
0.95
PE 34:2;
ME716368
1.05
0.95
PC 38:2;
ME716336
1.05
0.95
FA 22:6; (docosahexaenoic acid)
ME716287
1.05
0.95
FA 20:2; (eicosadienoic acid)
ME716279
1.05
0.95
FA 20:3; (homo-gamma-linolenic acid)
ME716281
1.05
0.95
SM d36:0;
ME716404
1.04
0.96
PI 36:2; PI 18:0-18:2;
ME716391
1.04
0.96
PE 38:6;
ME716375
1.04
0.96
PE 38:4; B
ME716374
1.04
0.96
PC 40:6; B
ME716346
1.04
0.96
PC 38:3;
ME716337
1.04
0.96
PC 34:1;
ME716319
1.04
0.96
FA 22:0; (behenic acid)
ME716284
1.04
0.96
FA 24:1; (nervonic acid)
ME716289
1.04
0.96
PE 36:3;
ME716371
1.08
0.92
FA 20:3; (eicosatrienoic acid)
ME716280
1.08
0.92
FA 14:1; (physeteric acid)
ME716268
1.08
0.92
FA 15:1;
ME716270
1.08
0.92
PI 40:6; PI 18:0-22:6;
ME716395
1.07
0.93
PI 34:2;
ME716390
1.07
0.93
PE 36:2;
ME716370
1.07
0.93
Ceramide d34:0;
ME716246
1.07
0.93
LPC 16:1;
ME716301
1.07
0.93
PC 36:1;
ME716326
1.06
0.94
FA 20:1; (eicosenoic acid)
ME716278
1.06
0.94
Cer-OS d41:3; Cer-OS d18:2/23:1;
ME716262
1.06
0.94
FA 18:1; (oleic acid)
ME716274
1.06
0.94
Ceramide d40:0;
ME716252
1.12
0.88
PC 40:4;
ME716342
1.11
0.89
PE 34:1;
ME716367
1.11
0.89
PC 40:5; B
ME716344
1.09
0.91
Ceramide d42:0;
ME716256
1.10
0.90
SM d42:0;
ME716419
1.10
0.90
FA 16:1; (palmitoleic acid)
ME716272
1.14
0.86
PC 32:1;
ME716315
1.16
0.84
PE p-38:6; or PE o-38:7;
ME716385
1.02
0.98
PE p-36:1; or PE o-36:2;
ME716378
1.02
0.98
PC 40:7;
ME716347
1.02
0.98
PC 36:5; B
ME716333
1.02
0.98
PC 36:3; B
ME716329
1.02
0.98
PC 36:2;
ME716327
1.02
0.98
FA 28:0; (montanic acid)
ME716291
1.02
0.98
FA 24:0; (lignoceric acid)
ME716288
1.02
0.98
FA 22:1; (erucic acid)
ME716285
1.02
0.98
1_PC 12:0/13:0; iSTD
ME716240
1.02
0.98
FA 16:0; (palmitic acid)
ME716271
1.02
0.98
PE p-36:5; or PE o-36:6;
ME716381
1.03
0.97
PE p-34:1; or PE o-34:2;
ME716376
1.03
0.97
PC 40:5; A
ME716343
1.03
0.97
PC 38:5; B
ME716340
1.03
0.97
PC 32:0;
ME716314
1.03
0.97
LPC 20:2;
ME716307
1.03
0.97
FA 14:0; (myristic acid)
ME716267
1.03
0.97
FA 26:0; (cerotic acid)
ME716290
1.03
0.97
SM d42:2; A
ME716421
1.00
1.00
PE p-36:4; or PE o-36:5;
ME716380
1.00
1.00
PC p-34:0; or PC o-34:1;
ME716350
1.00
1.00
PC 38:5; A
ME716339
1.00
1.00
PC 38:4; A
ME716338
1.00
1.00
PC 36:5; A
ME716332
1.00
1.00
PC 36:3; A
ME716328
1.00
1.00
PC 32:2;
ME716316
1.00
1.00
LPC 14:0;
ME716299
1.00
1.00
GlcCer d42:2;
ME716297
1.00
1.00
FA 18:2; (linoleic acid)
ME716275
1.00
1.00
FA 17:0; (margaric acid)
ME716273
1.00
1.00
FA 11:0; (undecylic acid)
ME716264
1.00
1.00
FA 10:0; (capric acid)
ME716263
1.00
1.00
Ceramide d40:2;
ME716254
1.00
1.00
Ceramide d36:1;
ME716249
1.00
1.00
1_PG 17:0/17:0; iSTD
ME716242
1.00
1.00
1_Ceramide d18:1/17:0; iSTD
ME716234
1.00
1.00
1_FA 16:0-d3; iSTD
ME716236
1.00
1.00
PI 38:5;
ME716394
1.01
0.99
PI 38:4; PI 18:0-20:4;
ME716393
1.01
0.99
PE p-40:7; or PE o-40:8;
ME716389
1.01
0.99
PE p-38:3; or PE o-38:4;
ME716382
1.01
0.99
PE 38:2;
ME716373
1.01
0.99
PE 36:1;
ME716369
1.01
0.99
PC 40:6; A
ME716345
1.01
0.99
PC 38:6;
ME716341
1.01
0.99
PC 36:4; B
ME716331
1.01
0.99
PC 34:4;
ME716322
1.01
0.99
PC 34:2;
ME716320
1.01
0.99
PC 33:1;
ME716317
1.01
0.99
FA 20:5; (eicosapentaenoic acid)
ME716283
1.01
0.99
FA 20:0; (arachidic acid)
ME716277
1.01
0.99
FA 18:3; (linolenic acid)
ME716276
1.01
0.99
FA 15:0; (pentadecylic acid)
ME716269
1.01
0.99
FA 13:0; (tridecylic acid)
ME716266
1.01
0.99
Ceramide d42:2; A
ME716258
1.01
0.99
FA 12:0; (lauric acid)
ME716265
1.01
0.99
SM d36:1;
ME716405
0.95
1.05
SM d30:1;
ME716396
0.95
1.05
PC p-38:4; or PC o-38:5; B
ME716360
0.95
1.05
PC 35:4;
ME716325
0.95
1.05
GlcCer d41:1;
ME716295
0.95
1.05
GlcCerd14:14E/20:02OH;
ME716298
0.95
1.05
Ceramide d39:1;
ME716251
0.95
1.05
Ceramide d32:1;
ME716244
0.95
1.05
Ceramide d33:1;
ME716245
0.95
1.05
SM d43:2;
ME716425
0.94
1.06
SM d42:2; B
ME716422
0.94
1.06
SM d41:1;
ME716417
0.94
1.06
SM d39:1;
ME716411
0.94
1.06
PC p-36:1; or PC o-36:2;
ME716354
0.94
1.06
PC p-34:1; or PC o-34:2; A
ME716351
0.94
1.06
PC 33:2;
ME716318
0.94
1.06
LPC 22:5;
ME716309
0.94
1.06
Ceramide d34:2;
ME716248
0.94
1.06
Ceramide d42:2; B
ME716259
0.94
1.06
SM d33:1;
ME716400
0.93
1.07
SM d36:2;
ME716406
0.93
1.07
PI 38:3; PI 18:0-20:3;
ME716392
0.99
1.01
PE p-40:6; or PE o-40:7;
ME716388
0.99
1.01
PE p-40:5; or PE o-40:6;
ME716387
0.99
1.01
PE p-36:2; or PE o-36:3;
ME716379
0.99
1.01
PE p-34:2; or PE o-34:3;
ME716377
0.99
1.01
PC p-38:4; or PC o-38:5; A
ME716359
0.99
1.01
PC p-34:1; or PC o-34:2; B
ME716352
0.99
1.01
PC 40:8;
ME716348
0.99
1.01
PC 37:2;
ME716334
0.99
1.01
LPC 20:1;
ME716306
0.99
1.01
LPC 18:1;
ME716304
0.99
1.01
GlcCer d42:1;
ME716296
0.99
1.01
FA 20:4; (arachidonic acid)
ME716282
0.99
1.01
Ceramide d34:1;
ME716247
0.99
1.01
1_PE 17:0/17:0; iSTD
ME716241
0.99
1.01
1_MAG 17:0/0:0/0:0; iSTD
ME716239
0.99
1.01
1_LPE 17:1; iSTD
ME716238
0.99
1.01
1_CUDA iSTD
ME716235
0.99
1.01
1_LPC 17:0; iSTD
ME716237
0.99
1.01
SM d44:2;
ME716426
0.98
1.02
SM d40:2; A
ME716414
0.98
1.02
SM d34:2;
ME716403
0.98
1.02
SM d34:1;
ME716402
0.98
1.02
SM d32:1;
ME716398
0.98
1.02
PE p-40:4; or PE o-40:5;
ME716386
0.98
1.02
PE p-38:5; or PE o-38:6;
ME716384
0.98
1.02
PE p-38:4; or PE o-38:5;
ME716383
0.98
1.02
PC p-44:4; or PC o-44:5;
ME716366
0.98
1.02
PC p-38:5; or PC o-38:6;
ME716361
0.98
1.02
PC p-36:3; or PC o-36:4;
ME716356
0.98
1.02
PC o-32:0;
ME716349
0.98
1.02
LPE 22:6;
ME716313
0.98
1.02
LPC 16:0;
ME716300
0.98
1.02
GlcCer d38:1;
ME716293
0.98
1.02
Ceramide d38:1;
ME716250
0.98
1.02
Ceramide d42:1;
ME716257
0.98
1.02
SM d42:1;
ME716420
0.97
1.03
SM d32:0;
ME716397
0.97
1.03
PC p-40:3; or PC o-40:4;
ME716362
0.97
1.03
PC p-38:3; or PC o-38:4;
ME716358
0.97
1.03
PC p-36:4; or PC o-36:5;
ME716357
0.97
1.03
PC 35:1;
ME716323
0.97
1.03
PC 34:3;
ME716321
0.97
1.03
LPE 20:4;
ME716312
0.97
1.03
LPE 18:2;
ME716311
0.97
1.03
LPC 18:0; B
ME716303
0.97
1.03
LPC 18:0; A
ME716302
0.97
1.03
1_SM d18:1/17:0; iSTD
ME716243
0.97
1.03
Ceramide d40:1;
ME716253
0.97
1.03
SM d42:3;
ME716423
0.96
1.04
SM d40:1;
ME716413
0.96
1.04
SM d38:1;
ME716409
0.96
1.04
SM d34:0;
ME716401
0.96
1.04
SM d32:2;
ME716399
0.96
1.04
PC p-42:4; or PC o-42:5;
ME716364
0.96
1.04
PC p-40:4; or PC o-40:5;
ME716363
0.96
1.04
PC p-34:2; or PC o-34:3;
ME716353
0.96
1.04
PC 37:4;
ME716335
0.96
1.04
PC 36:4; A
ME716330
0.96
1.04
PC 35:2;
ME716324
0.96
1.04
LPE 16:0;
ME716310
0.96
1.04
LPC 20:3;
ME716308
0.96
1.04
GlcCer d40:1;
ME716294
0.96
1.04
Ceramide d41:1;
ME716255
0.96
1.04
Ceramide d44:1;
ME716261
0.96
1.04
SM d39:2;
ME716412
0.85
1.15
PC p-42:5; or PC o-42:6;
ME716365
0.89
1.11
SM d36:3;
ME716407
0.88
1.12
SM d37:1;
ME716408
0.90
1.10
SM d40:2; B
ME716415
0.90
1.10
SM d40:3;
ME716416
0.92
1.08
Ceramide d43:1;
ME716260
0.92
1.08
PC p-36:2; or PC o-36:3;
ME716355
0.92
1.08
SM d43:1;
ME716424
0.91
1.09
SM d41:2;
ME716418
0.91
1.09
LPC 18:2;
ME716305
0.91
1.09
SM d38:2;
ME716410
0.91
1.09
Factors:
F1
liver_cancer_outcome:Case
F2
liver_cancer_outcome:Control
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
This repository is under review for potential modification in compliance with Administration directives
Terms of use
Site map
Contact
NMDR Personnel